Acute Hemodynamic Effects of CJ-10513, an Angiotensin IIReceptor Antahonest, in Dog Treated with High Friquency Ventricular Pacing

안지오텐신 ll 수용체 길항약 CJ-10513이 고민도 심실 pacing 천에서의 혈행동태에 미치는 영향

  • 김영훈 (제일제당(주)종합연구소) ;
  • 정성목 (제일제당(주)종합연구소) ;
  • 신재규 (제일제당(주)종합연구소) ;
  • 최재묵 (제일제당(주)종합연구소) ;
  • 정성학 (제일제당(주)종합연구소) ;
  • 배훈 (제일제당(주)종합연구소) ;
  • 이건호 (제일제당(주)종합연구소) ;
  • 김제학 (제일제당(주)종합연구소) ;
  • 안양수 (제일제당(주)종합연구소)
  • Published : 1998.06.01

Abstract

Acute hemodynamic effects of CJ-18513, a non-peptide angiotensin IIreceptor antagonist, were examined in mongrel dogs treated with high frequency ventricular pacing for one week. Rapid ventricular pacing reduced mean blood pressure (mBP), Lvdp/dt and cardiac output (CO), and increased the left ventricular end-diastolic pressure (LVEDP) and pulmonary capillary wedge pressure (PCWP). Continuous infusion of CJ-10513 at doses of 10 and 20$\mu$g/kg/min, respectively, for 30 minutes reduced mBP, LVEDP and myocardial oxygen consumption rate (MVO,) and shifted the cardiac function curve (CO-LVEDP ourve) to the left in this dog model. In conclusion, CJ-10513 decreased the preload and afterload and increased the cardiac function in dogs with pacing-induced heart failure.

Keywords